Beam Therapeutics Inc
BEAM
Market Cap$2.01B
Close$
$-24.21
219.2% downside
Current Fair Value
219.2% downsideOvervalued by 219.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.01 Billion |
|---|---|
| Enterprise Value | $1.73 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.58 |
| Beta | 2.08 |
| Outstanding Shares | 87,975,311 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.54 |
|---|---|
| PEG | -42.3 |
| Price to Sales | - |
| Price to Book Ratio | 1.69 |
| Enterprise Value to Revenue | 27.17 |
| Enterprise Value to EBIT | -3.96 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Insider Trades
ESG Score
No data